DOP008. Human intestinal Vδ2+ T-cells acquire antigen-presenting potency upon exposure to microbial phosphoantigen: modulation by mucosal inflammation and vedolizumab therapy
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.